Akebia Therapeutics, Inc.

AKBA

$0.98

+0.31%

2026-09-03 16:00:01 EDT+$0.00

Healthcare

Biotechnology

NASDAQ

Active Trading

Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for ...

Historical Employee Count of AKBA

Current

194

Change

+7.18%

Minimum

167

Maximum

426

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	194	10-K	Feb 26, 2026	View
Dec 31, 2024	181	10-K	Mar 13, 2025	View
Dec 31, 2023	167	10-K	Mar 14, 2024	View
Dec 31, 2022	205	10-K	Mar 10, 2023	View
Dec 31, 2021	426	10-K	Mar 1, 2022	View

Supply Chain of AKBA

Upstream / Downstream / Proxies

Upstream

Patheon Manufacturing Services LLC (Thermo Fisher Scientific)NYSE:TMOSiegfried Evionnaz SA (Siegfried Holding AG)SIX:SFZNSTA Pharmaceutical Hong Kong Limited (WuXi AppTec / WuXi STA)HKEx:2359 Patheon Inc. (Thermo Fisher Scientific — Ontario site)NYSE:TMO

Downstream

U.S. Renal Care (USRC)DaVita Inc.NYSE:DVA Fresenius Medical Care AG & Co. KGaANYSE:FMS McKesson CorporationNYSE:MCK Cencora, Inc. (formerly AmerisourceBergen)NYSE:COR Cardinal Health, Inc.NYSE:CAH Fresenius Medical Care RxNYSE:FMSMitsubishi Tanabe Pharma Corporation (MTPC)TSE:4508Panion & BF Biotech, Inc.TWSE:1760Cyclerion Therapeutics, Inc.NASDAQ:CYCN Viatris Inc. (formerly Mylan)NASDAQ:VTRSCSL Vifor (CSL Limited)ASX:CSL

Proxies

FibroGen, Inc.NASDAQ:FGEN GSK plcNYSE:GSK Ardelyx, Inc.NASDAQ:ARDX Unicycive Therapeutics, Inc.NASDAQ:UNCY

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer